TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways

Blood

Volumn 100, Issue 4, 2002, Pages 1438-1448

  Ho, Jenny M Y ^a,b,c,d,e   Nguyen, Melody H H ^a,b,c,d,e   Dierov, Jamil K ^a,b,c,d,e   Badger, Karla M ^a,b,c,d,e   Beattie, Bryan K ^a,b,c,d,e   Tartaro, Piero ^a,b,c,d,e   Haq, Rizwan ^a,b,c,d,e   Zanke, Brent W ^a,b,c,d,e   Carroll, Martin P ^a,b,c,d,e   Barber, Dwayne L ^a,b,c,d,e  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d CROSS CANCER INSTITUTE   (Canada)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; ISOPROTEIN; JANUS KINASE; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLALANINE; RAS PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETV6; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; BONE MARROW TRANSPLANTATION; CELL KINETICS; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE MUTATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL LINE; ENZYME ACTIVATION; GRB2 ADAPTOR PROTEIN; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; ONCOGENE PROTEINS, FUSION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENYLALANINE; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION; TYROSINE;

EID: 0037103262     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Chronic myeloid leukemia
2. Tyrosyl phosphorylation and dna binding activity of signal transducers and activators of transcription (stat) proteins in hematopoietic cell lines transformed by Bcr/Abl
3. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats
4. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
5. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia
6. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene
7. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation
8. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
9. Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant
10. Dominant negative MYC blocks transformation by ABL oncogenes
11. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5; 12) chromosomal translocation
12. The novel activation of ABL by fusion to an ets-related gene, TEL
13. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia
14. The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): Molecular cloning of both reciprocal transcripts
15. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma
16. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25)
17. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia
18. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
19. The SH2 inositol 5-phosphatase Ship-1 is recruited in an SH2-dependent manner to the erythropoietin receptor
20. Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein
21. Erythropoietin activates Raf1 by an Shc-independent pathway in CTLL-EPO-R cells
22. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis
23. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein
24. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway
25. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway
26. Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl
27. SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase
28. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene
29. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia
30. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl
31. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase
32. Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells
33. The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myeologenous leukemia-like disease by bcr/abl
34. The Grb2 binding site is required for induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase
35. The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl
36. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines
37. The TEL/PDGFβR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways
38. The TEL/PDGFβR fusion protein activates STAT1 and STAT5: A common mechanism of transformation by tyrosine kinase fusion proteins
39. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes
40. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling
41. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
42. TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3′-kinase/protein kinase B signaling pathway
43. Erythropoietin and interleukin-2 activate distinct JAK kinase family members
44. The TEL gene products: Nuclear phosphoproteins with DNA binding properties
45. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity
46. Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2
47. Molecular cloning and chromosomal localization in human and mouse of the SH2-containing inositol phosphatase, INPP5D (SHIP). Amgen EST Program
48. A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL-3
49. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions
50. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins
51. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene
52. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases
53. The function of GRB2 in linking the insulin receptor to Ras signaling pathways
54. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation
55. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: Implications for insulin control of ras signalling
56. A new function for a phosphotyrosine phosphatase: Linking GRB2-Sos to a receptor tyrosine kinase
57. Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3′-kinase
58. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor β to Ras
59. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase
60. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation
61. Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL
62. The inositol 5ε′-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation
63. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav
64. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway
65. Activation of p38 MAP kinase pathway by erythropoietin and intedeukin-3
66. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation
67. Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin
68. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis
69. Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hemopoietic cell proliferation
70. The stress-activated protein kinase pathways
71. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3
72. Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of intedeukin-4
73. A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells
74. Ras-dependent activation of c-Jun N-terminal kinase/stress-activated protein kinase in response to interleukin-3 stimulation in hematopoietic BaF3 cells
75. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow
76. Cell cycle-dependent activation of Ras